Published in Br J Cancer on June 09, 2009
NADPH oxidase overexpression in human colon cancers and rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Int J Cancer (2010) 1.01
Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype. J Hepatol (2010) 0.96
MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells. Gastroenterology (2010) 0.95
NF-κB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis. J Pathol (2014) 0.91
Human serum-derived hydroxy long-chain fatty acids exhibit anti-inflammatory and anti-proliferative activity. J Exp Clin Cancer Res (2011) 0.88
A systematic survey of the response of a model NF-κB signalling pathway to TNFα stimulation. J Theor Biol (2011) 0.84
Increased IKKα expression in the basal layer of the epidermis of transgenic mice enhances the malignant potential of skin tumors. PLoS One (2011) 0.84
Interleukin-6 mediated upregulation of CYP1B1 and CYP2E1 in colorectal cancer involves DNA methylation, miR27b and STAT3. Br J Cancer (2014) 0.82
Inhibition of intestinal adenoma formation in APC(Min/+) mice by Riccardin D, a natural product derived from liverwort plant Dumortiera hirsuta. PLoS One (2012) 0.82
Enhanced NF-κB activity impairs vascular function through PARP-1-, SP-1-, and COX-2-dependent mechanisms in type 2 diabetes. Diabetes (2013) 0.82
Apurinic/apyrimidinic endonuclease-1 (APE-1) is overexpressed via the activation of NF-κB-p65 in MCP-1-positive esophageal squamous cell carcinoma tissue. J Clin Biochem Nutr (2013) 0.80
Expression of nuclear transcription factor kappa B in locally advanced human cervical cancer treated with definitive chemoradiation. Int J Radiat Oncol Biol Phys (2010) 0.80
Diallyl Disulfide (DADS), a Constituent of Garlic, Inactivates NF-κB and Prevents Colitis-Induced Colorectal Cancer by Inhibiting GSK-3β. Cancer Prev Res (Phila) (2016) 0.80
Cyclooxygenase-2 expression in the tumor environment is associated with poor prognosis in colorectal cancer patients. Oncol Lett (2013) 0.78
Deciphering the role of nuclear and cytoplasmic IKKα in skin cancer. Oncotarget (2016) 0.77
Bardoxolone Methyl Prevents High-Fat Diet-Induced Colon Inflammation in Mice. J Histochem Cytochem (2016) 0.77
Mucin 1 Regulates Cox-2 Gene in Pancreatic Cancer. Pancreas (2015) 0.76
Celecoxib and fish oil: a combination strategy for decreased inflammatory mediators in early stages of experimental mammary cancer. Inflammopharmacology (2016) 0.75
NF-kappaB at the crossroads of life and death. Nat Immunol (2002) 12.98
Aspirin and the risk of colorectal cancer in women. N Engl J Med (1995) 9.59
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology (1994) 8.79
Aspirin use and reduced risk of fatal colon cancer. N Engl J Med (1991) 7.85
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med (1993) 6.13
Colorectal cancer. Lancet (1999) 4.72
Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res (1998) 3.20
COX-2: a molecular target for colorectal cancer prevention. J Clin Oncol (2005) 3.15
Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest (2000) 3.03
Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res (1997) 2.99
Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem (1993) 2.61
Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res (1992) 2.47
Sulindac for polyposis of the colon. J Surg Oncol (1983) 2.34
Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene (1999) 2.33
Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Cancer Res (2002) 1.92
Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens. Cancer Lett (1999) 1.64
Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene. Biochem Biophys Res Commun (1994) 1.44
Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps. Cancer Res (2002) 1.39
Involvement of nuclear factor kappa B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes. Arthritis Rheum (1997) 1.33
Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer. Br J Cancer (2000) 1.31
Vitamin C inhibits NF-kappa B activation by TNF via the activation of p38 mitogen-activated protein kinase. J Immunol (2000) 1.26
Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro. J Clin Endocrinol Metab (2006) 1.24
Regulation of immune responses by NF-kappa B/Rel transcription factor. J Exp Med (1998) 1.17
Comparative clinicopathological and immunohistochemical study of ras and p53 in flat and polypoid type colorectal tumours. Gut (1994) 1.04
PPAR-gamma is expressed and NF-kB pathway is activated and correlates positively with COX-2 expression in stromal myofibroblasts surrounding colon adenocarcinomas. J Cancer Res Clin Oncol (2005) 1.04
Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas. Clin Cancer Res (2004) 1.04
Up-regulation of cyclooxygenase-2 by interleukin-1beta in colon carcinoma cells. Cell Signal (2005) 0.92
Increased protein expression of both inducible nitric oxide synthase and cyclooxygenase-2 in human colon cancers. Cancer Lett (2005) 0.92
Upregulation of cyclooxygenase-2 is accompanied by increased expression of nuclear factor-kappa B and I kappa B kinase-alpha in human colorectal cancer epithelial cells. Br J Cancer (2003) 0.90
Cytoplasmic phospholipase A2 alpha overexpression in stromal cells is correlated with angiogenesis in human colorectal cancer. Mod Pathol (2005) 0.86
Selenomethionine regulates cyclooxygenase-2 (COX-2) expression through nuclear factor-kappa B (NF-kappaB) in colon cancer cells. Cancer Biol Ther (2005) 0.85
Differential stromal and epithelial localization of cyclooxygenase-2 (COX-2) during colorectal tumorigenesis. J Exp Clin Cancer Res (2005) 0.84
Cyclooxygenase-2 expression is associated with increased size in human sporadic colorectal adenomas. Anticancer Res (2005) 0.83
Cyclooxygenase-2 in cancer cells and macrophages induces colon cancer cell growth by cigarette smoke extract. Eur J Pharmacol (2005) 0.83
Increased cyclooxygenase-2 expression in large flat colorectal tumors (laterally spreading tumors). J Gastroenterol (2003) 0.83
Cyclooxygenase-2 in sporadic colorectal polyps: immunohistochemical study and its importance in the early stages of colorectal tumorigenesis. Pathol Res Pract (2005) 0.82
Cyclooxygenase-2 expression in stromal tumors of the gastrointestinal tract. Hum Pathol (2003) 0.82
The involvement of nuclear factor-kappa B in cyclooxygenase-2 overexpression in murine colon cancer cells transduced with herpes simplex virus thymidine kinase gene. Cancer Gene Ther (2006) 0.79
Cyclooxygenase-2 expression in human adenocarcinoma cell line HT29 cl.19A. Anticancer Res (1998) 0.77
The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study. Am J Pathol (1988) 2.53
Evaluation of seven oestrogen receptor beta antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue. J Pathol (2002) 2.13
The satisfaction and savings of early discharge with drain in situ following axillary lymphadenectomy in the treatment of breast cancer. Eur J Surg Oncol (1995) 1.55
Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancer. Carcinogenesis (2003) 1.54
CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans. Cancer Res (1994) 1.49
Blood flow in breast cancer and fibroadenoma estimated by colour Doppler ultrasonography. Br J Surg (1995) 1.48
Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: identification of interleukin-8 as a potential regulatory factor in breast tumours. Int J Cancer (1997) 1.47
Role of magnetic resonance imaging in the diagnosis and single-stage surgical resection of invasive lobular carcinoma of the breast. Br J Surg (2002) 1.44
RT-PCR detection of cytokine transcripts in a series of cultured human meningiomas. J Pathol (1996) 1.43
Breast cancer following augmentation mammoplasty - a review of its impact on prognosis and management. J Plast Reconstr Aesthet Surg (2007) 1.42
Breast cancer: locoregional control and survival. Clin Oncol (R Coll Radiol) (2001) 1.39
Assessing the impact of chemotherapy-induced nausea and vomiting on patients' daily lives: a modified version of the Functional Living Index-Emesis (FLIE) with 5-day recall. Support Care Cancer (2003) 1.36
Small is beautiful: microRNAs and breast cancer-where are we now? J Pathol (2008) 1.35
Immunohistochemical detection of ERbeta in breast cancer: towards more detailed receptor profiling? Br J Cancer (2001) 1.32
Properties and characteristics of the dyes injected to assist axillary sentinel node localization in breast surgery. Eur J Surg Oncol (2006) 1.31
Role of fine-needle aspiration cytology and needle-core biopsy in the diagnosis of lobular carcinoma of the breast. Br J Surg (1994) 1.25
Perinatal and reproductive factors: a report on haematological malignancies from the UKCCS. Eur J Cancer (2005) 1.25
Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity. Br J Cancer (2009) 1.24
Mitogenicity of human fibroblasts in vivo for human breast cancer cells. Br J Surg (1987) 1.20
Nucleosomes bind to cell surface proteoglycans. J Biol Chem (1999) 1.20
Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging. Oncol Rep (2005) 1.15
Functional relevance of antiemetic control. Experience using the FLIE questionnaire in a randomised study of the NK-1 antagonist aprepitant. Eur J Cancer (2003) 1.10
Genetic changes in breast cancer detected by comparative genomic hybridisation. Int J Cancer (2000) 1.10
Postoperative wound complications and systemic recurrence in breast cancer. Br J Cancer (2007) 1.10
Causes of false-negative sentinel node biopsy in patients with breast cancer (Br J Surg 2013; 100: 775-783). Br J Surg (2013) 1.07
Evidence that aspartic acid 301 is a critical substrate-contact residue in the active site of cytochrome P450 2D6. J Biol Chem (1995) 1.05
Do metastases metastasize? J Pathol (2004) 1.05
Stressful life events and difficulties and onset of breast cancer: case-control study. BMJ (1999) 1.03
Detection and measurement of MeIQx in human urine after ingestion of a cooked meat meal. Carcinogenesis (1989) 1.02
Acellular dermal matrix (ADM) assisted breast reconstruction procedures: joint guidelines from the Association of Breast Surgery and the British Association of Plastic, Reconstructive and Aesthetic Surgeons. Eur J Surg Oncol (2013) 1.02
Intestinal lymphangiectasia, a disease characterized by selective loss of naive CD45RA+ lymphocytes into the gastrointestinal tract. Eur J Immunol (1998) 1.00
Cell biology of pulmonary neuroepithelial bodies--validation of an in vitro model. I. Effects of hypoxia and Ca2+ ionophore on serotonin content and exocytosis of dense core vesicles. Anat Rec (1993) 0.99
Steroid hormone receptor expression in male breast cancer. Eur J Surg Oncol (2005) 0.99
Meta-analysis of superficial versus deep injection of radioactive tracer and blue dye for lymphatic mapping and detection of sentinel lymph nodes in breast cancer. Br J Surg (2014) 0.99
Extra-nuclear location of histones in activated human peripheral blood lymphocytes and cultured T-cells. Biochem Pharmacol (1995) 0.98
Inhibition of protein kinase C mediated signal transduction by tamoxifen. Importance for antitumour activity. Biochem Pharmacol (1986) 0.98
Systematic review and meta-analysis of cytokeratin 19-based one-step nucleic acid amplification versus histopathology for sentinel lymph node assessment in breast cancer. Br J Surg (2014) 0.97
Colorectal cancer in a rural population. Ir J Med Sci (1984) 0.97
Pyoderma gangrenosum--an unusual differential diagnosis for acute infection. Breast (2004) 0.96
A novel cell array technique for high-throughput, cell-based analysis. In Vitro Cell Dev Biol Anim (2005) 0.95
Collagenase III: a superior enzyme for complete disaggregation and improved viability of normal and malignant human breast tissue. In Vitro Cell Dev Biol Anim (1996) 0.95
PRFLL--a Pinus radiata homologue of FLORICAULA and LEAFY is expressed in buds containing vegetative shoot and undifferentiated male cone primordia. Planta (1998) 0.95
Expression of alternatively spliced estrogen receptor alpha mRNAs is increased in breast cancer tissues. J Steroid Biochem Mol Biol (2001) 0.95
Anti-HIV type 1 activity of sulfated derivatives of dextrin against primary viral isolates of HIV type 1 in lymphocytes and monocyte-derived macrophages. AIDS Res Hum Retroviruses (1997) 0.94
Common genetic variation contributes significantly to the risk of childhood B-cell precursor acute lymphoblastic leukemia. Leukemia (2012) 0.94
Metabolism of the food derived mutagen and carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP) by human liver microsomes. Carcinogenesis (1994) 0.93
Cosmetic results of immediate breast reconstruction post-mastectomy: a follow-up study. Br J Surg (1986) 0.93
Laparoscopic cholecystectomy: incidental carcinoma of the gallbladder with abdominal wall and axillary node metastasis. HPB Surg (1997) 0.93
Genetic events during the transformation of a tamoxifen-sensitive human breast cancer cell line into a drug-resistant clone. Cancer Genet Cytogenet (2001) 0.92
The measurement of MeIQx adducts with mouse haemoglobin in vitro and in vivo: implications for human dosimetry. Carcinogenesis (1991) 0.91
Infection by HIV-1 blocked by binding of dextrin 2-sulphate to the cell surface of activated human peripheral blood mononuclear cells and cultured T-cells. Br J Pharmacol (1994) 0.91
Antiproliferative effects of idoxifene in a placebo-controlled trial in primary human breast cancer. Clin Cancer Res (2000) 0.91
Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breast. Int J Oncol (1999) 0.91
Effect of cruciferous vegetable consumption on heterocyclic aromatic amine metabolism in man. Carcinogenesis (2001) 0.91
Changes in expression of steroid receptors, their downstream target genes and their associated co-regulators during the sequential acquisition of tamoxifen resistance in vitro. Int J Oncol (2007) 0.91
Upregulation of cyclooxygenase-2 is accompanied by increased expression of nuclear factor-kappa B and I kappa B kinase-alpha in human colorectal cancer epithelial cells. Br J Cancer (2003) 0.90
Surgery for malignant melanoma: from which limb should the graft be taken? Br J Surg (1986) 0.90
Expression of prostate specific antigen in male breast cancer. J Clin Pathol (2005) 0.90
Malignant melanoma of the hand and foot: diagnosis and management. Br J Surg (1985) 0.90
Para-ileostomy hernia: failure of a local repair technique. Br J Surg (1986) 0.90
Breast cancer subtypes: response to radiotherapy and potential radiosensitisation. Br J Radiol (2013) 0.90
Metallothionein expression in duct carcinoma in situ of the breast. Hum Pathol (1995) 0.89
Vascular endothelial growth factor in premenopausal women--indicator of the best time for breast cancer surgery? Br J Cancer (1998) 0.89
The cystic fibrosis delta F508 gene mutation and cancer. Hum Mutat (1997) 0.89
Activity of interferon alpha, interleukin 6 and insulin in the regulation of differentiation in A549 alveolar carcinoma cells. Br J Cancer (1995) 0.88
Mechanisms of FGFR3 actions in endocrine resistant breast cancer. Int J Cancer (2011) 0.88
Interaction of the transactivating protein HIV-1 tat with sulphated polysaccharides. Biochem Pharmacol (1999) 0.88
Sentinel lymph node biopsy in male breast cancer patients. Eur J Surg Oncol (2004) 0.88
Results of a national training programme in sentinel lymph node biopsy for breast cancer. Br J Surg (2013) 0.86
Oncological aspects of breast reconstruction. Breast (2005) 0.86
Fibroblast stimulation of breast cancer cell growth in a serum-free system. Br J Cancer (1993) 0.86
Monophasic sarcomatoid carcinoma of the breast. Histopathology (1998) 0.86
Mass spectrometric detection and measurement of N2-(2'-deoxyguanosin-8-yl)PhIP adducts in DNA. J Chromatogr B Biomed Sci Appl (2000) 0.85
Novel translocation of the BCL10 gene in a case of mucosa associated lymphoid tissue lymphoma. Genes Chromosomes Cancer (2000) 0.85
Secondary loss of deoxyguanosine kinase activity in purine nucleoside phosphorylase deficient mice. Biochim Biophys Acta (1994) 0.84
Mutational spectra of the dietary carcinogen 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine(PhIP) at the Chinese hamsters hprt locus. Carcinogenesis (1996) 0.84
Childhood leukaemia risks: from unexplained findings near nuclear installations to recommendations for future research. J Radiol Prot (2014) 0.83
Molecular dosimetry of the food-borne carcinogen MeIQx using adducts of serum albumin. Carcinogenesis (1993) 0.83
Augmentation mammoplasty: effect on diagnosis of breast cancer. J Plast Reconstr Aesthet Surg (2007) 0.82
Dual immunocytochemical analysis of oestrogen and epidermal growth factor receptors in human breast cancer. Br J Cancer (1994) 0.82
The mutagenicity of benzo[a]pyrene in mouse small intestine. Carcinogenesis (1999) 0.82
Cytokine expression in human anterior pituitary adenomas. Clin Endocrinol (Oxf) (1996) 0.82
Effect of dietary supplementation with a Saccharomyces cerevisiae mannan oligosaccharide on the bacterial community structure of broiler cecal contents. Appl Environ Microbiol (2011) 0.82
A mechanistic basis for the role of cycle arrest in the genetic toxicology of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Toxicol Sci (2005) 0.82
Strong association of the HLA-DP6 supertype with childhood leukaemia is due to a single allele, DPB1*0601. Leukemia (2009) 0.81
Effect of growth factors on growth of bovine parathyroid cells in serum-free medium. World J Surg (1996) 0.81
Oestrogen receptor beta: how should we measure this? Br J Cancer (2002) 0.81
The value of screening in siblings of patients with abdominal aortic aneurysm. Eur J Vasc Endovasc Surg (2003) 0.80
17Beta-hydroxysteroid dehydrogenase type 1, 2, 3, and 4 expression and enzyme activity in human anterior pituitary adenomas. J Clin Endocrinol Metab (1999) 0.80
Enzymatic studies of the activation of heterocyclic food mutagens in man. Princess Takamatsu Symp (1995) 0.79
Genetic analysis of PHIP intestinal mutations in MutaMouse. Mutagenesis (1998) 0.79
Metastatic melanoma of the tonsil. J Laryngol Otol (1999) 0.79
Malignant melanoma of the penis. Eur J Surg Oncol (1996) 0.79
Oestrogen receptor beta immunohistochemistry: time to get it right? J Clin Pathol (2008) 0.79
Screening mammography for women starting hormone replacement therapy. Lancet (1999) 0.79
The potential role of ER beta isoforms in the clinical management of breast cancer. Histopathology (2008) 0.78